StockNews.com Begins Coverage on Diffusion Pharmaceuticals (NASDAQ:DFFN)

StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ:DFFN opened at $3.05 on Friday. The business’s 50 day simple moving average is $3.58 and its two-hundred day […]

Related Keywords

Virginia ,United States ,Charlottesville , ,Jpmorgan Chase Co ,Diffusion Pharmaceuticals ,Diffusion Pharmaceuticals Inc ,Securities Exchange Commission ,Diffusion Pharmaceuticals Stock Performance ,News Ratings For Diffusion Pharmaceuticals Daily ,Nasdaq ,Diffusion Pharmaceuticals Company Profile ,Free Report ,Get Free Report ,Pharmaceuticals Inc ,Trans Sodium Crocetinate ,Diffusion Pharmaceuticals Daily ,Nasdaq Dffn ,Dffn ,Medical ,Initiated Coverage ,Stocknews Com ,